|
Restenosis
Citations 11-20 of 20 total displayed.
|
Past content
(since Aug 2008):
|
- Original Article
A Randomized Controlled Trial of Angiography Versus Intravascular Ultrasound-Directed Bare-Metal Coronary Stent Placement (The AVID Trial)
- Robert J. Russo, Patricia D. Silva, Paul S. Teirstein, Michael J. Attubato, Charles J. Davidson, Anthony C. DeFranco, Peter J. Fitzgerald, Steven L. Goldberg, James B. Hermiller, Martin B. Leon, Frederick S. Ling, Jennifer E. Lucisano, Richard A. Schatz, S. Chiu Wong, Neil J. Weissman, and David M. Zientek
Circ Cardiovasc Interv published February 20, 2009, doi:10.1161/CIRCINTERVENTIONS.108.778647
[Abstract]
- Editorials
Drug-Eluting or Bare-Metal Stents for ST Elevation Myocardial Infarction Can Observational Data Balance the Risk Benefit Equation?
- Donald E. Cutlip
Circ Cardiovasc Interv 2008;1:161-163, doi:10.1161/CIRCINTERVENTIONS.108.834036
[Full text]
- Original Articles
Clinical Outcome After Primary Percutaneous Coronary Intervention With Drug-Eluting and Bare Metal Stents in Patients With ST-Segment Elevation Myocardial Infarction
- Lisette Okkels Jensen, Michael Maeng, Per Thayssen, Anne Kaltoft, Hans Henrik Tilsted, Morten Bøttcher, Jens Flensted Lassen, Knud Nørregaard Hansen, Lars Romer Krusell, Klaus Rasmussen, Knud Erik Pedersen, Lars Pedersen, Søren Paaske Johnsen, Henrik Toft Sørensen, and Leif Thuesen
Circ Cardiovasc Interv 2008;1:176-184, doi:10.1161/CIRCINTERVENTIONS.108.794578
[Abstract]
[Full text]
- Original Articles
Poor 1-Year Outcomes After Percutaneous Coronary Interventions in Systemic Lupus Erythematosus: Report From the National Heart, Lung, and Blood Institute Dynamic Registry
- Kathleen Maksimowicz-McKinnon, Faith Selzer, Susan Manzi, Kevin E. Kip, Suresh R. Mulukutla, Oscar C. Marroquin, Thomas C. Smitherman, Lewis H. Kuller, David O. Williams, and Mary Chester M. Wasko
Circ Cardiovasc Interv 2008;1:201-208, doi:10.1161/CIRCINTERVENTIONS.108.788745
[Abstract]
[Full text]
- Original Articles
Inhibition of Apoptosis Through Localized Delivery of Rapamycin-Loaded Nanoparticles Prevented Neointimal Hyperplasia and Reendothelialized Injured Artery
- Maram K. Reddy, Jaspreet K. Vasir, Sanjeeb K. Sahoo, Tapan K. Jain, Murali M. Yallapu, and Vinod Labhasetwar
Circ Cardiovasc Interv 2008;1:209-216, doi:10.1161/CIRCINTERVENTIONS.108.830018
[Abstract]
[Full text]
- Controversies in Interventional Cardiology
Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual Antiplatelet Therapy After Drug-Eluting Stents Should Not Be Continued for More Than 1 Year and Preferably Indefinitely
- Antonio Colombo and Robert T. Gerber
Circ Cardiovasc Interv 2008;1:226-232, doi:10.1161/CIRCINTERVENTIONS.108.810853
[Full text]
- Original Articles
Impact of In-Stent Minimal Lumen Area at 9 Months Poststent Implantation on 3-Year Target Lesion Revascularization–Free Survival: A Serial Intravascular Ultrasound Analysis From the TAXUS IV, V, and VI Trials
- Hiroshi Doi, Akiko Maehara, Gary S. Mintz, Neil J. Weissman, Alan Yu, Hong Wang, Lazar Mandinov, Jeffrey J. Popma, Stephen G. Ellis, Eberhard Grube, Keith D. Dawkins, and Gregg W. Stone
Circ Cardiovasc Interv 2008;1:111-118; published online before print as doi:10.1161/CIRCINTERVENTIONS.108.784660
[Abstract]
[Full text]
- Special Report
Drug-Eluting Stents in Preclinical Studies: Updated Consensus Recommendations for Preclinical Evaluation
- Robert S. Schwartz, Elazer Edelman, Renu Virmani, Andrew Carter, Juan F. Granada, Greg L. Kaluza, Nicolas A.F. Chronos, Keith A. Robinson, Ron Waksman, Judah Weinberger, Gregory J. Wilson, and Robert L. Wilensky
Circ Cardiovasc Interv 2008;1:143-153, doi:10.1161/CIRCINTERVENTIONS.108.789974
[Abstract]
[Full text]
- Original Article
Impact of In-stent Minimal Lumen Area at 9 Months Post-Stent Implantation on 3-Year Target Lesion Revascularization-Free Survival: A Serial Intravascular Ultrasound Analysis from the TAXUS IV, V, and VI Trials
- Hiroshi Doi, Akiko Maehara, Gary S. Mintz, Neil J. Weissman, Alan Yu, Hong Wang, Lazar Mandinov, Jeffrey J. Popma, Stephen G. Ellis, Eberhard Grube, Keith D. Dawkins, and Gregg W. Stone
Circ Cardiovasc Interv published September 3, 2008, doi:10.1161/CIRCINTERVENTIONS.108.784660
[Abstract]
- Original Articles
Drug-Eluting Stents Versus Bare-Metal Stents for Off-Label Indications: A Propensity Score–Matched Outcome Study
- David Austin, Keith G. Oldroyd, Alex McConnachie, Rachel Slack, Hany Eteiba, Andrew D. Flapan, Kevin P. Jennings, Robin J. Northcote, Alastair C.H. Pell, Ian R. Starkey, and Jill P. Pell
Circ Cardiovasc Interv 2008;1:45-52, doi:10.1161/CIRCINTERVENTIONS.108.769042
[Abstract]
[Full text]
|
|
